Physician profile
Adam Arnofsky
NPI 1245301332
$131,518.12
in general payments reported to CMS, 2019-2025
39 companies · $41K in 2025
The $41K reported for 2025 was more than what 96% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,851 · 2020: $1,549 · 2021: $7,933 · 2022: $27K · 2023: $25K · 2024: $25K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $63K · Consulting Fee: $12K · Food and Beverage: $11K · Travel and Lodging: $4,834 · Entertainment: $19.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $62,595.00 |
| Consulting Fee | $12,000.00 |
| Food and Beverage | $11,079.54 |
| Travel and Lodging | $4,833.75 |
| Entertainment | $19.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $91,224.64 | 2021-2025 | Corevalve Evolut R |
| Abbott Laboratories | $14,841.51 | 2019-2025 | Amplatzer Amulet, Navitor, Mitraclip |
| Edwards Lifesciences Corporation | $10,187.36 | 2019-2025 | Pascal, Evoque, Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $8,303.99 | 2020-2025 | Lifevest |
| Abiomed | $2,674.02 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $1,237.95 | 2019-2020 | |
| Atricure, INC. | $473.66 | 2019-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Boston Scientific Corporation | $358.53 | 2019-2024 | Sentinel |
| Davol INC. | $239.81 | 2024-2025 | Channel Drain |
| Cvrx, INC. | $231.55 | 2020-2025 | Barostim Neo System |
| La Jolla Pharmaceutical Company | $173.63 | 2022-2025 | Giapreza |
| Cardiva Medical, INC. | $169.70 | 2024 | Savvywire |
| Cook Medical LLC | $138.27 | 2023 | Cook |
| W. L. Gore & Associates, INC. | $131.78 | 2022-2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Getinge USA Sales, LLC | $124.50 | 2019-2024 | Vasoview Hemopro 2 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $122.68 | 2022 | |
| Terumo Cardiovascular Systems Corporation | $109.20 | 2019 | |
| Medistim USA, INC. | $81.96 | 2020 | |
| Nuwellis, INC. | $71.77 | 2020 | |
| Lsi Solutions INC | $66.18 | 2025 | Cor-Knot |
| Astrazeneca Pharmaceuticals LP | $61.21 | 2019 | |
| Innovation Technologies INC | $53.67 | 2022 | |
| Portola Pharmaceuticals, LLC | $52.14 | 2019-2020 | |
| Angiodynamics, INC. | $46.57 | 2019 | |
| Janssen Pharmaceuticals, INC | $45.81 | 2020-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $38.89 | 2019-2020 | |
| Heartflow, INC. | $38.36 | 2024-2025 | |
| Bolton Medical INC | $33.23 | 2019 | |
| Bard Access Systems, INC. | $28.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $25.08 | 2019 | |
| Opsens INC. | $19.57 | 2023 | Optowire |
| Solventum Corporation | $18.45 | 2025 | Activ.A.C. |
| Daiichi Sankyo INC. | $17.00 | 2023 | Injectafer |
| Mallinckrodt Hospital Products INC. | $14.25 | 2020 | |
| Kci USA, INC. | $14.09 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $12.97 | 2019 | |
| Amarin Pharma, INC. | $12.90 | 2019 | |
| Csl Behring | $12.59 | 2019 | |
| Cardiovascular Systems INC. | $10.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Arnofsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.